IBC’s 4th Annual Biosimilars Asia 2013

IBC’s 4th Annual Biosimilars Asia 2013

IBC’s 4th Annual Biosimilars Asia 2013, a leading business conference in Aisa focus on bringing together global industry leaders in addressing the latest concerns, is to be staged at Grand Hyatt Shanghai during May 20-23, 2013.

Lively debates, insightful case studies and in-depth market analysis provide maximum learning. Keep abreast of the latest in biosimilars development and commercial strategies. Engage with your peers in competing to bring affordable medicines to market. Speakers from major and regional pharma, and biotech companies will join leading biosimilar companies to share their experiences and knowledge. Covering both strategic and technical aspects, it is THE ONLY all-encompassing conference and YOUR MUST ATTEND conference on biosimilars in the region. 

NEW in 2013:
The keynote plenary sessions, Track 1 on Strategy and Commercial Success plus Track 2 on Biomanufacturing and Production of mAbs, aims to provide in-depth insights to the biosimilars environment. Be privy to industry insights and the latest updates on how the industry is positioning to take advantage of emerging opportunities:
• NEW, MUST ATTEND for CSOs, Heads of R&D and Manufacturing! Focused technical know-how on complex biosimilars in a separate new track
• Keynote plenary sessions + 2 tracks: Commercial Strategy + Biomanufacturing and Production of mAbs
• Reformulated 2013 Agenda on the rise of authorized biosimilars, market acceptance & production standards for successful manufacturing of mAbs
• Asia’s BIGGEST meeting on Biosimilars: 40+ global and regional speakers in over 30 sessions
• IN-DEPTH technical case studies, EXCLUSIVE 1ST TIME joint presentation by Merck Serono and Dr Reddy’s
• PRESCRIBER & PAYER perspectives in the quest for more affordable & accessible biologic medicines
• DEEP-DIVE workshops to boost your success in biosimilars
• GREATER networking and collaboration opportunities from 3 co-located conferences under one roof!